Total Payments
$206,308
2024 Payments
$53,790
Companies
18
Transactions
145
Medicare Patients
1,307
Medicare Billing
$122,671
Payment Breakdown by Category
Other$181,120 (87.8%)
Consulting$13,558 (6.6%)
Food & Beverage$5,468 (2.7%)
Research$3,164 (1.5%)
Gifts$2,796 (1.4%)
Education$201.82 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $176,520 | 69 | 85.6% |
| Consulting Fee | $13,558 | 9 | 6.6% |
| Food and Beverage | $5,468 | 55 | 2.7% |
| Honoraria | $4,600 | 3 | 2.2% |
| Unspecified | $3,164 | 1 | 1.5% |
| Gift | $2,796 | 3 | 1.4% |
| Education | $201.82 | 5 | 0.1% |
Payments by Type
General
$203,144
144 transactions
Research
$3,164
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $78,994 | 50 | $0 (2024) |
| Biogen, Inc. | $51,227 | 37 | $0 (2024) |
| Genentech USA, Inc. | $49,564 | 26 | $0 (2023) |
| Amgen Inc. | $12,184 | 7 | $0 (2024) |
| Horizon Therapeutics plc | $4,650 | 4 | $0 (2023) |
| Genentech, Inc. | $3,306 | 3 | $0 (2023) |
| Novartis Pharma AG | $3,164 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $2,808 | 4 | $0 (2019) |
| GENZYME CORPORATION | $217.75 | 2 | $0 (2019) |
| UCB, Inc. | $43.27 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53,790 | 27 | EMD Serono, Inc. ($30,279) |
| 2023 | $50,803 | 31 | EMD Serono, Inc. ($28,658) |
| 2022 | $57,186 | 38 | Biogen, Inc. ($29,019) |
| 2021 | $17,382 | 11 | Genentech USA, Inc. ($10,035) |
| 2020 | $9,920 | 12 | Genentech USA, Inc. ($9,785) |
| 2019 | $10,835 | 8 | Genentech USA, Inc. ($10,653) |
| 2018 | $6,037 | 7 | Novartis Pharma AG ($3,164) |
| 2017 | $354.10 | 11 | Biogen, Inc. ($110.39) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| 12/17/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| 12/02/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Neurology | ||||||
| 11/26/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Biogen, Inc. | TYSABRI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,614.00 | General |
| Category: Neurology | ||||||
| 11/12/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Neurology | ||||||
| 11/12/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,083.00 | General |
| Category: Neurology | ||||||
| 11/07/2024 | Biogen, Inc. | TYSABRI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,614.00 | General |
| Category: Neurology | ||||||
| 10/23/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Neurology | ||||||
| 10/18/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $11.06 | General |
| 09/27/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Neurology | ||||||
| 08/28/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $99.00 | General |
| Category: Neurology | ||||||
| 08/13/2024 | Biogen, Inc. | TYSABRI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,304.00 | General |
| Category: Neurology | ||||||
| 08/12/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Neurology | ||||||
| 07/24/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Neurology | ||||||
| 07/19/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,934.00 | General |
| Category: Neurology | ||||||
| 07/03/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/03/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/19/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Neurology | ||||||
| 04/10/2024 | Biogen, Inc. | TYSABRI (Biological) | Consulting Fee | Cash or cash equivalent | $269.00 | General |
| Category: Neurology | ||||||
| 04/10/2024 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $135.00 | General |
| 04/03/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Neurology | ||||||
| 03/28/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/25/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $69.00 | General |
| Category: Neurology | ||||||
| 03/13/2024 | Biogen, Inc. | TYSABRI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,228.00 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Publication support research related | Novartis Pharma AG | $3,164 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 353 | 386 | $132,448 | $34,707 |
| 2022 | 3 | 302 | 373 | $88,876 | $31,340 |
| 2021 | 3 | 308 | 367 | $70,930 | $31,722 |
| 2020 | 4 | 344 | 399 | $76,281 | $24,902 |
Total Patients
1,307
Total Services
1,525
Medicare Billing
$122,671
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 80 | 82 | $30,845 | $8,979 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 124 | 144 | $36,993 | $8,180 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 48 | $22,027 | $6,737 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 79 | $24,774 | $6,200 | 25.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 20 | 20 | $10,089 | $2,389 | 23.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $7,719 | $2,221 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 155 | 197 | $39,514 | $13,220 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 130 | $29,143 | $11,383 | 39.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $7,672 | $2,480 | 32.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 17 | 17 | $7,155 | $2,165 | 30.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $5,393 | $2,093 | 38.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 149 | 196 | $30,881 | $14,691 | 47.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 97 | 109 | $21,110 | $10,385 | 49.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 22 | 22 | $8,153 | $2,818 | 34.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $6,019 | $2,756 | 45.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 25 | 25 | $4,767 | $1,071 | 22.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 167 | 193 | $37,271 | $11,773 | 31.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 139 | 168 | $26,582 | $9,063 | 34.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 27 | 27 | $9,898 | $3,139 | 31.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 11 | 11 | $2,531 | $927.42 | 36.6% |
About Dr. Jason Silversteen, DO
Dr. Jason Silversteen, DO is a Neurology healthcare provider based in Newark, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1174783237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Silversteen, DO has received a total of $206,308 in payments from pharmaceutical and medical device companies, with $53,790 received in 2024. These payments were reported across 145 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($176,520).
As a Medicare-enrolled provider, Silversteen has provided services to 1,307 Medicare beneficiaries, totaling 1,525 services with total Medicare billing of $122,671. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Newark, DE
- Active Since 06/12/2008
- Last Updated 09/10/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1174783237
Products in Payments
- Mavenclad (Drug) $50,059
- OCREVUS (Biological) $40,721
- MAVENCLAD (Drug) $25,160
- TYSABRI (Biological) $22,417
- Ocrevus (Biological) $10,808
- Tysabri (Biological) $10,613
- UPLIZNA (Biological) $9,000
- GILENYA (Drug) $5,960
- UPLIZNA (Drug) $4,650
- Enspryng (Biological) $1,260
- AUBAGIO (Drug) $217.75
- Rebif (Biological) $82.75
- Non-Covered Product (Drug) $61.96
- Briviact (Drug) $43.27
- Aimovig (Biological) $33.75
- Epidiolex (Drug) $29.48
- ZEPOSIA (Drug) $29.08
- AVONEX (Biological) $28.71
- Hizentra (Biological) $22.52
- TEGSEDI (Drug) $22.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Newark
Dr. Justin Martello, M.d, M.D
Neurology — Payments: $357,121
Neurology $357,121
Deren Huang, Md, MD
Neurology — Payments: $346,599
Neurology $346,599
Waimei Tai, Md, MD
Neurology — Payments: $147,202
Neurology $147,202
Dr. Garland Tang, M.d, M.D
Neurology — Payments: $34,114
Neurology $34,114
Dr. Even Wang, M.d, M.D
Neurology — Payments: $33,873
Neurology $33,873
Stuart Cook, M.d, M.D
Neurology — Payments: $22,674
Neurology $22,674